Joinn Laboratories(China)Co.,Ltd. provided earnings guidance for the year ended December 31, 2023. For the year, the company expects that the operating revenue of the Group in 2023 would range from approximately RMB 2,267,971,000 to RMB 2,494,768,100, representing an increase of approximately RMB 0 to RMB 226,797,100 as compared with the corresponding period of the previous year, with a year-to-year increase of approximately 0% to 10.0%. It is expected that net profit attributable to shareholders of the Company in 2023 would range from approximately RMB 310,912,000 to RMB 418,337,800, representing a decrease of approximately RMB 655,919,400 to RMB 763,345,100, as compared with the corresponding period of the previous year, with a year-to-year decrease of approximately 61.1% to 71.1%.

It is expected that net profit attributable to shareholders of the Company after deducting non-recurring gains and losses in 2023 would range from approximately RMB 285,629,900 to RMB 387,573,400, representing a decrease of approximately RMB 631,862,000 to RMB 733,805,500 as compared with the corresponding period of the previous year, with a year-to- year decrease of approximately 62.0% to 72.0%.